US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.
The market research available can provide investors and analysts credible information on the direction of pharmaceuticals, anesthesia, drug delivery, pricing, regulations and policy being developed to ensure that knowledgeable and informed decisions are made regarding industry direction.
  • Biopharmaceuticals (221)
  • Diseases & Conditions (4429)
  • Drug Delivery (186)
  • Therapeutic Area (7018)
  • Vaccines (643)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Out-of-Pocket Healthcare Expenditures in the United States
5/15/2015 | published by: Kalorama Information
... is the result of a variety of factors including an aging U.S. population, rising utilization of medical products and services, and ongoing cutbacks to both public (federal and state) and private health coverage. Over the ...  |  read more...
USD 1,500
Cardiac Rhythm Management Device Markets
5/1/2015 | published by: Kalorama Information
... particularly arrhythmias and congestive heart failure. This report,  C ardiac Rhythm Device Markets,  includes cardiac rhythm management devices with both external and internal applications.  Major segments include defibrillators: electrical devices that deliver therapeutic levels of ...  |  read more...
USD 3,995
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... I) (Hurler Syndrome ). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Report helps to ...  |  read more...
USD 1,250
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... III) (Sanfilippo Syndrome ). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) Report helps to ...  |  read more...
USD 1,250
Mucositis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Mucositis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Mucositis- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Mumps-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Mumps Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Mumps- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Mycoses-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Mycoses Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Mycoses- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Mycosis Fungoides-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Mycosis Fungoides Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Mycosis Fungoides- Pipeline ...  |  read more...
USD 1,250
Consumer Health in Nigeria
5/7/2015 | published by: Euromonitor International
... war against counterfeit and adulterated drugs. The high cost of medical care is another factor responsible for growth, with patients preferring to seek self-medication or pharmacists’ advice at the initial onset of less serious illnesses. ...  |  read more...
USD 2,650
Research and Development in the Physical, Engineering, and Life Sciences - The 2015 U.S. Market Research Report
6/1/2015 | published by: Kentley Insights
... Engineering, and Life Sciences industry in the United States. These Market Research Reports are based on billions of data points created from millions of annual comprehensive business surveys. Used for a range of strategic purposes, ...  |  read more...
USD 195
Cameroon Pharmaceuticals and Healthcare Report Q3 2015
5/20/2015 | published by: BMI Research
... of the industry will continue to bediamond mining with continued investment, both domestic and international, in this segment helping tosupport steady growth in output over our forecast period. While the Angolan government is increasinglyturning its ...  |  read more...
USD 1,295
Myelofibrosis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Myelofibrosis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Myelofibrosis- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Myeloproliferative Disorders-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Myeloproliferative Disorders Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Myeloproliferative Disorders- Pipeline ...  |  read more...
USD 1,250
Myopia-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Myopia Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Myopia- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Narcolepsy-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Narcolepsy Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Narcolepsy- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Nasopharyngeal Cancer-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Nasopharyngeal Cancer Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Nasopharyngeal Cancer- Pipeline ...  |  read more...
USD 1,250
Nasopharyngitis (Common Cold)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Nasopharyngitis (Common Cold) Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Neisseria Meningitidis Infections-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Neisseria Meningitidis Infections Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Hair). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) Report helps to identify emerging players with ...  |  read more...
USD 1,250
Neuralgia-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Neuralgia Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Neuralgia- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Neuro Endocrine (Carcinoid) Carcinoma-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Neuro Endocrine (Carcinoid) Carcinoma Report helps to identify emerging players with potentially strong product information and create effective counter-strategies ...  |  read more...
USD 1,250
Neuroendocrine Carcinoma-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Neuroendocrine Carcinoma Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Neuroendocrine Carcinoma- Pipeline ...  |  read more...
USD 1,250
Neurofibromatoses-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Neurofibromatoses Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Neurofibromatoses- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Nocturia-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Nocturia Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Nocturia- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Jordan Pharmaceuticals and Healthcare Report Q3 2015
5/20/2015 | published by: BMI Research
... of the industry will continue to bediamond mining with continued investment, both domestic and international, in this segment helping tosupport steady growth in output over our forecast period. While the Angolan government is increasinglyturning its ...  |  read more...
USD 1,295
< prev 1    3  4  5  6  7  8  9  10